Primary study · included by 1 review
Phenotypic frailty and multimorbidity are independent 18-year mortality risk indicators in older men : The Helsinki Businessmen Study (HBS).
Strandberg 2021 · Strandberg Timo E, Lindström Linda, Jyväkorpi Satu, et al. · European geriatric medicine · 2021
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
All-cause mortality Non-robust (frail, prefrail or equivalent) on any frailty instrument vs Robust (no signs of frailty) · Follow-up 1 to 15 years | HR 1.83 [1.70, 1.97] | 56 studies | GRADE not reported |
All-cause mortality Non-robust (frail, prefrail or equivalent) on any frailty instrument vs Robust (no signs of frailty) · Follow-up 1 to 15 years | HR 1.11 [1.11, 1.29] | NR | GRADE not reported |
All-cause mortality Non-robust (frail, prefrail or equivalent) on any frailty instrument vs Robust (no signs of frailty) · Follow-up 1 to 15 years | HR 1.46 [1.27, 1.68] | NR | GRADE not reported |
1 including review in total.